Literature DB >> 29209894

Mitochondrial energy metabolism and signalling in human glioblastoma cell lines with different PTEN gene status.

Marina Comelli1, Ivan Pretis2, Alessia Buso2, Irene Mavelli2,3.   

Abstract

Glioblastomas epidemiology and aggressiveness demand for a well characterization of biochemical mechanisms of the cells. The discovery of oxidative tumours related to chemoresistance is changing the prevalent view of dysfunctional mitochondria in cancer cells. Thus, glioblastomas metabolism is now an area of intense research, wherein was documented a high heterogeneity in energy metabolism and in particular in mitochondrial OxPhos. We report results gained by investigating mitochondrial OxPhos and bioenergetics, in a model of three human glioblastoma cell lines characterized by a different PTEN gene status. Functional data are analysed in relation to the expression levels of some main transcription factors and signalling proteins, which can be involved in the regulation of mitochondrial biogenesis and activity. Collectively, our observations indicate for the three cell lines a similar bioenergetic phenotype maintaining a certain degree of mitochondrial oxidative activity, with some difference for PTEN-wild type SF767 cells respect to PTEN-deleted A172 and U87MG characterized by a loss-of-function point mutation of PTEN. SF767 has lower ATP content and higher ADP/ATP ratio, higher AMPK activating-phosphorylation evoking energy impairment, higher OxPhos complexes and PGC1α-Sirt3-p53 protein abundance, in line with a higher respiration. Finally, SF767 shows a similar mitochondrial energy supply, but higher non-phosphorylating respiration linked to dissipation of protonmotive force. Intriguingly, it is now widely accepted that a regulated mitochondrial proton leak attenuate ROS generation and in tumours may be at the base of pro-survival advantage and chemoresistance.

Entities:  

Keywords:  Bioenergetic phenotype; Cancer metabolism; High-resolution respirometry; Human glioblastoma cell lines; Mitochondria-related signalling proteins; Seahorse XFe24

Mesh:

Substances:

Year:  2017        PMID: 29209894     DOI: 10.1007/s10863-017-9737-5

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  56 in total

1.  Nonoxidative glucose consumption during focal physiologic neural activity.

Authors:  P T Fox; M E Raichle; M A Mintun; C Dence
Journal:  Science       Date:  1988-07-22       Impact factor: 47.728

2.  Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.

Authors:  K Imamura; T Ogura; A Kishimoto; M Kaminishi; H Esumi
Journal:  Biochem Biophys Res Commun       Date:  2001-09-21       Impact factor: 3.575

3.  Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines.

Authors:  Corinne E Griguer; Claudia R Oliva; G Yancey Gillespie
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

Review 4.  The on-off switches of the mitochondrial uncoupling proteins.

Authors:  Vian Azzu; Martin D Brand
Journal:  Trends Biochem Sci       Date:  2009-12-16       Impact factor: 13.807

5.  Mitochondrial uncoupling inhibits p53 mitochondrial translocation in TPA-challenged skin epidermal JB6 cells.

Authors:  Fei Wang; Xueqi Fu; Xia Chen; Xinbin Chen; Yunfeng Zhao
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

6.  Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Gene Kim; Madhu Gupta; Senthilkumar B Rajamohan; Jyothish B Pillai; Sadhana Samant; P V Ravindra; Ayman Isbatan; Mahesh P Gupta
Journal:  J Biol Chem       Date:  2009-11-24       Impact factor: 5.157

Review 7.  Genetic pathways to primary and secondary glioblastoma.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 8.  PTEN signaling in brain: neuropathology and tumorigenesis.

Authors:  R Endersby; S J Baker
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

Review 9.  Role of Akt in human malignant glioma: from oncogenesis to tumor aggressiveness.

Authors:  Emmanuel Chautard; Zangbéwendé Guy Ouédraogo; Julian Biau; Pierre Verrelle
Journal:  J Neurooncol       Date:  2014-01-30       Impact factor: 4.130

10.  Reconstructed Metabolic Network Models Predict Flux-Level Metabolic Reprogramming in Glioblastoma.

Authors:  Emrah Özcan; Tunahan Çakır
Journal:  Front Neurosci       Date:  2016-04-18       Impact factor: 4.677

View more
  6 in total

1.  Antineoplastic activity of a novel ruthenium complex against human hepatocellular carcinoma (HepG2) and human cervical adenocarcinoma (HeLa) cells.

Authors:  Carlos Eduardo Alves de Souza; Amanda do Rocio Andrade Pires; Carolina Riverin Cardoso; Rose Maria Carlos; Silvia Maria Suter Correia Cadena; Alexandra Acco
Journal:  Heliyon       Date:  2020-05-06

2.  Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression.

Authors:  Sara Franceschi; Debora Corsinovi; Francesca Lessi; Elena Tantillo; Paolo Aretini; Michele Menicagli; Claudia Scopelliti; Prospero Civita; Francesco Pasqualetti; Antonio G Naccarato; Michela Ori; Chiara M Mazzanti
Journal:  EBioMedicine       Date:  2018-10-09       Impact factor: 8.143

3.  Prediction of regulatory targets of alternative isoforms of the epidermal growth factor receptor in a glioblastoma cell line.

Authors:  Claus Weinholdt; Henri Wichmann; Johanna Kotrba; David H Ardell; Matthias Kappler; Alexander W Eckert; Dirk Vordermark; Ivo Grosse
Journal:  BMC Bioinformatics       Date:  2019-08-22       Impact factor: 3.169

Review 4.  Multifaceted Regulation of PTEN Subcellular Distributions and Biological Functions.

Authors:  Tian Liu; Yiwei Wang; Yubing Wang; Andrew M Chan
Journal:  Cancers (Basel)       Date:  2019-08-26       Impact factor: 6.639

Review 5.  Transcriptional Regulation of Energy Metabolism in Cancer Cells.

Authors:  Sara Rodríguez-Enríquez; Álvaro Marín-Hernández; Juan Carlos Gallardo-Pérez; Silvia Cecilia Pacheco-Velázquez; Javier Alejandro Belmont-Díaz; Diana Xochiquetzal Robledo-Cadena; Jorge Luis Vargas-Navarro; Norma Angélica Corona de la Peña; Emma Saavedra; Rafael Moreno-Sánchez
Journal:  Cells       Date:  2019-10-09       Impact factor: 6.600

6.  The Suitability of Glioblastoma Cell Lines as Models for Primary Glioblastoma Cell Metabolism.

Authors:  Anya L Arthurs; Damien J Keating; Brett W Stringer; Simon J Conn
Journal:  Cancers (Basel)       Date:  2020-12-11       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.